SCHEMBL22700362

SCHEMBL22700362

CCOC(=O)COc1cc2c(O)c(-c3c(C)cc4c(C(C)C)c(O)c(O)c(C=O)c4c3O)c(C)cc2c(C(C)C)c1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 13/20 0.62
BCL2 P10415 12/20 0.62
AKR1B1 P15121 5/20 0.62
BCL2L1 Q07817 3/20 0.62
KDM4E B2RXH2 2/20 0.62
MEN1 O00255 2/20 0.62
NPC1 O15118 2/20 0.62
USP2 O75604 2/20 0.62
ALDH1A1 P00352 2/20 0.62
LMNA P02545 2/20 0.62
POLB P06746 2/20 0.62
GAA P10253 2/20 0.62
MAPT P10636 2/20 0.62
THRB P10828 2/20 0.62
HPGD P15428 2/20 0.62
ALOX12 P18054 2/20 0.62
MAPK1 P28482 2/20 0.62
BLM P54132 2/20 0.62
KMT2A Q03164 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22700701 0.90 MCL1 (0.70) MCL1BCL2AKR1B1BCL2L1KDM4E
SCHEMBL22700547 0.89 MCL1 (0.60) MCL1BCL2AKR1B1BCL2L1KDM4E
SCHEMBL22700372 0.86 AKR1B1 (0.51) MCL1BCL2AKR1B1BCL2L1KDM4E
SCHEMBL22700384 0.82 MCL1 (0.71) MCL1BCL2AKR1B1BCL2L1KDM4E
SCHEMBL22700525 0.82 MCL1 (0.64) MCL1BCL2AKR1B1BCL2L1KDM4E
SCHEMBL22700664 0.81 MCL1 (0.67) MCL1BCL2AKR1B1BCL2L1KDM4E
Gossypol SCHEMBL6683213 0.80 MCL1 (0.82) MCL1BCL2AKR1B1BCL2L1KDM4E
Gossypol SCHEMBL28960798 0.79 MCL1 (0.89) MCL1BCL2AKR1B1BCL2L1KDM4E
Gossypol SCHEMBL29355719 0.79 MCL1 (1.00) MCL1BCL2AKR1B1BCL2L1KDM4E
Gossypol SCHEMBL30260519 0.79 MCL1 (1.00) MCL1BCL2AKR1B1BCL2L1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200369618-A1 ASYMMETRIC DERIVATIVES OF POLYPHENOLS OF THE DINAPHTHALINE SERIES, PROCESS OF PREPARING AND USE THEREOF Nearmedic International Limited (CY) 2020-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200369618-A1 ASYMMETRIC DERIVATIVES OF POLYPHENOLS OF THE DINAPHTHALINE SERIES, PROCESS OF PREPARING AND USE THEREOF DNM2, DNM1, MAVS MCL1 3671/4885BCL2 3675/4885AKR1B1 1151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.